Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers

被引:131
作者
Kloor, M
Becker, C
Benner, A
Woerner, SM
Gebert, J
Ferrone, S
Doeberitz, MV
机构
[1] Heidelberg Univ, Inst Mol Pathol, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Cent Unit Biostat, D-6900 Heidelberg, Germany
[3] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA
关键词
D O I
10.1158/0008-5472.CAN-05-0044
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In colorectal cancer, the immune response is particularly pronounced against tumors displaying the high microsatellite instability (MSI-H) phenotype. MSI-H tumors accumulate mutations affecting microsatellites located within protein encoding regions (coding microsatellites, cMS), which lead to translational shifts of the respective reading frames. Consequently, novel tumor-specific frameshift-derived neopeptides (FSP) are generated and presented by MSI-H tumor cells, thus eliciting effective cytotoxic immune responses. To analyze whether the immunoselective pressure was reflected by the phenotype of MSI-H colorectal cancer cells, we compared here the expression of antigen processing machinery (A-PM) components and human leukocyte antigen (HLA) class I antigen subunits in 20 MSI-H and 20 microsatellite-stable (MSS) colorectal cancer using a panel of newly developed APM component-specific monoclonal antibodies. In addition, we did a systematic analysis of mutations at cMS located within APM genes and beta 2-microglobulin (beta M-2). Total HLA class I antigen loss was observed in 12 (60.0%) of the 20 MSI-H lesions compared with only 6 (30.0%) of the 20 MSS colorectal cancer lesions. Moreover, total loss of membraneous HLA-A staining was significantly more frequent in MSI-H colorectal cancer (P = 0.0024). Mutations at cMS of beta(2)m and genes encoding APM components (TAPI and TAP2) were detected in at least 7 (35.0%) of 20 MSI-H colorectal cancers but in none of the MSS colorectal cancers (P = 0.0002). These data show that defects of HLA class I antigen processing and presentation seem to be significantly more frequent in MSI-H than in MSS colorectal cancer, suggesting that in MSI-H colorectal cancer the immunoselective pressure leads to the outgrowth of cells with defects of antigen presentation.
引用
收藏
页码:6418 / 6424
页数:7
相关论文
共 36 条
  • [1] Down-regulation of HLA class I antigen processing molecules:: An immune escape mechanism of renal cell carcinoma?
    Atkins, D
    Ferrone, S
    Schmahl, GE
    Störkel, S
    Seliger, B
    [J]. JOURNAL OF UROLOGY, 2004, 171 (02) : 885 - 889
  • [2] Mutations of the β2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides
    Benitez, R
    Godelaine, D
    Lopez-Nevot, MA
    Brasseur, F
    Jiménez, P
    Marchand, M
    Oliva, MR
    van Baren, N
    Cabrera, T
    Andry, G
    Landry, C
    Ruiz-Cabello, F
    Boon, T
    Garrido, F
    [J]. TISSUE ANTIGENS, 1998, 52 (06): : 520 - 529
  • [3] Selection for beta(2)-microglobulin mutation in mismatch repair-defective colorectal carcinomas
    Bicknell, DC
    Kaklamanis, L
    Hampson, R
    Bodmer, WF
    Karran, P
    [J]. CURRENT BIOLOGY, 1996, 6 (12) : 1695 - 1697
  • [4] BETA(2)-MICROGLOBULIN GENE-MUTATIONS - A STUDY OF ESTABLISHED COLORECTAL CELL-LINES AND FRESH TUMORS
    BICKNELL, DC
    ROWAN, A
    BODMER, WF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) : 4751 - 4755
  • [5] Boland CR, 1998, CANCER RES, V58, P5248
  • [6] Tumour immunology
    Boon, T
    Van den Eynde, B
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (02) : 129 - 130
  • [7] Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases
    Buckowitz, A
    Knaebel, HP
    Benner, A
    Bläker, H
    Gebert, J
    Kienle, P
    Doeberitz, MV
    Kloor, M
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (09) : 1746 - 1753
  • [8] Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways:: β2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors
    Cabrera, CM
    Jiménez, P
    Cabrera, T
    Esparza, C
    Ruiz-Cabello, F
    Garrido, F
    [J]. TISSUE ANTIGENS, 2003, 61 (03): : 211 - 219
  • [9] CHANG CC, 2004, KEIO J MED, V52, P220
  • [10] Immunoproteasome subunits LMP2 and LMP7 downregulation in primary malignant melanoma lesions: association with lack of spontaneous regression
    Dissemond, J
    Goette, P
    Moers, J
    Lindeke, A
    Goos, M
    Ferrone, S
    Wagner, SN
    [J]. MELANOMA RESEARCH, 2003, 13 (04) : 371 - 377